Czechia· CZ-0255074
PONVORY
A ponesimod product containing ponesimod, registered in Czechia by Laboratoires Juvisé Pharmaceuticals, Villeurbanne. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Ponesimod is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AE04 (ponesimod), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Ponesimod · ATC L04AE04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ponesimod costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ponesimod · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$69.77
- CH Switzerland$69.06
The record
At a glance
SÚKL (Czech Republic)- Active substance
- PONESIMOD
- Manufacturer
- Laboratoires Juvisé Pharmaceuticals, Villeurbanne
- Country
- Czechia (CZ)
- ATC code
- L04AE04
- ATC class
- Ponesimod
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl02550742+2+2+1+1+1+1+1+3CZK 22489.32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ponesimod in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPonvory 10mg tabletsJuvise Pharmaceuticals
- SwitzerlandPonvory 10 mg, FilmtablettenMedius AG
- NorwayPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- FinlandPonvoryLaboratoires Juvise Pharmaceuticals
- FrancePONVORY 2 mg + 3 mg + 4 mg + 5 mg + 6 mg + 7 mg + 8 mg + 9 mg + 10 mg, comprimé pelliculéLABORATOIRES JUVISE PHARMACEUTICALS
- IrelandPonvory 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+10 mg film-coated tabletsLaboratoires Juvise Pharmaceuticals
- IcelandPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- ItalyPONVORY*14 cpr rivestite confezione di inizio trattamentoLAB.JUVISE' PHARMACEUTICALS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ponvory
- Liechtenstein · Ponvory
- Norway · Ponvory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/499943ac-8459-4445-807c-e32398227b1a GET /v1/drugs/499943ac-8459-4445-807c-e32398227b1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "2+3+4+5+6+7+8+9+10MG",
"pack_size": "2+2+2+1+1+1+1+1+3",
"substance": "PONESIMOD",
"cz_kod_sukl": "0255074",
"product_type": "CH",
"substance_codes": "19043,19043,19043,19043,19043,19043,19043,19043,19043",
"registration_state": "R",
"registration_number": "EU/1/21/1550/001"
}See everything about ponesimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.